3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hyperthermia
6
Rectal Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Hepatocellular
3
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Liver Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Locally Advanced Rectal Cancer
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Cholangiocarcinoma
1
Anus Neoplasms
1
Anastomotic Leak
1
Interventions
Capecitabine
20
Oxaliplatin
13
Irinotecan
8
spartalizumab
6
tislelizumab
4
Radiation
4
Neoadjuvant Therapy
4
Immune Checkpoint Inhibitors
4
Fluorouracil
4
toripalimab
3
sintilimab
2
camrelizumab
2
Radiotherapy
2
Leucovorin
2
Celecoxib
2
veliparib
1
peposertib
1
nimotuzumab
1
irinotecan sucrosofate
1
XELOX
1
Thymalfasin
1
Radiotherapy, Intensity-Modulated
1
Injections
1
HMPL-013
1
Folfox protocol
1
Diathermy
1
Combined Modality Therapy
1
Chemoradiotherapy
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Rectal Cancer
×
Diathermy
×
Gastrointestinal
×
Clear all
NCT02290574
2019-11-01
NEOTREAT
Samsung Medical Center
Phase NA
Terminated
14 enrolled
7 charts